One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Inari Medical now clears that threshold, with a jump from 72 to 81 Thursday.
IBD's proprietary RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Inari Medical is within a buy range after clearing a 53.67 buy point in a cup with handle. The proper buying range is up to 5% above the initial entry. Once a stock hits that benchmark, it's best to hold off investing and wait for it to set up another buying opportunity.
Inari Medical showed 0% EPS growth in the latest quarterly report. Sales gains came in at 21%.
The company holds the No. 39 rank among its peers in the Medical-Products industry group. Globus Medical, LeMaitre Vascular and Insulet are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
